Tipsheet
What matters at India’s listed companies
Earnings · Pharmaceuticals · Micro cap

Gujarat Inject Q1 net profit rises to ₹1.25 crore on solar trading

Net profit of ₹1.25 crore marks 69% of FY26 full-year profit, driven by a 414% revenue surge from the solar module business. The results were already disclosed in an earlier board filing.

8 earlier stories on Gujarat Inject (Kerala) Ltd.
Mkt cap₹180 cr
P/E99.23×
ROE0.97%
Debt / eq.0.00
₹1.25 crore Q1 FY27 net profit, up from ₹0.07 crore a year ago

What's new

  • Net profit rose to ₹1.25 crore from ₹0.07 crore YoY.
  • Revenue from operations surged 414% to ₹12.45 crore, powered by solar module trading.
  • The quarter already equals 69% of the full-year profit earned in FY26.

Why this matters

For a ₹180 crore market-cap firm, a ₹1.25 crore quarterly profit is a step change. The solar module business is now the dominant driver, and the proposed name change to Regenova Renwtech signals a permanent pivot from pharmaceuticals. But these numbers were already out, so the release is a recap, not a surprise.

What we're watching

  • Whether solar module revenue can sustain this pace through the rest of FY27.
  • The timeline for the name change to Regenova Renwtech Limited.
  • Any further clarity on the MD transition from the late chairman to Murli Shivshankaran Nair.

The full read

Gujarat Inject (Kerala) Ltd reported a Q1 net profit of ₹1.25 crore against ₹0.07 crore a year ago, as revenue jumped 414% to ₹12.45 crore on solar module trading. The quarter alone delivered 69% of the company's full-year FY26 profit. For a ₹180 crore nano-cap, these are strong numbers. But the release is a formality: the same results were already on the exchanges from an earlier board outcome. The headline is the pivot—solar trading is now the core business, and the proposed name change to Regenova Renwtech cements that. The question isn't what the quarter delivered; it's whether the momentum can last.

Questions answered

How did Gujarat Inject achieve such a big profit jump?
The company ramped up its solar module trading business, which drove revenue up 414% to ₹12.45 crore. Net profit soared to ₹1.25 crore from ₹0.07 crore a year earlier.
Was this profit unexpected?
No. The same numbers were disclosed in an earlier board-meeting outcome filing on the same day. The media release adds no material new information.
What is the significance of the 69% of FY26 profit figure?
It means the company earned more than two-thirds of last year's full-year net profit in just three months, highlighting the improved operating leverage from the solar business.
Why is the company changing its name to Regenova Renwtech?
The name change reflects a strategic shift toward renewable energy. The company has already moved into solar module trading, and the new name positions it as a clean-energy player.
Who is the new managing director?
Murli Shivshankaran Nair has been appointed, filling the top post after the chairman's death. His background is in plastics, not pharmaceuticals or solar, so the appointment was previously reported.
Mentioned: Gujarat Inject (Kerala) Ltd · ₹1.25 crore profit · 414% revenue growth
Primary source BSE · NSE · Tijori

An independent reading of the company's own disclosure — the primary filing above is the final word.

Company snapshot

Gujarat Inject (Kerala) Ltd.

Pharmaceuticals
₹197 cr
P/E 65.83×

Latest quarter · Jun 2026

Sales₹12 cr
Net profit₹1 cr
Op. margin+13.6%
EPS₹0.09

Strength & growth

Debt / equity0.00×
Current ratio40.77×
Sales CAGR+124.8%
  1. 15 Jul 2026 · 12:54 PM IST Gujarat Inject Q1 net profit rises to ₹1.25 crore on solar trading
  2. 7d ago Gujarat Inject Q1 net profit jumps to ₹125.16 lakh on solar trading
  3. 7d ago Gujarat Inject Q1 net profit jumps to ₹125.16 lakh on solar module trading
  4. 16d ago Gujarat Inject fills top post after chairman's death, but new MD is from plastics
  5. 28d ago Gujarat Inject loses Chairman, CFO & Whole-Time Director in single death